Literature DB >> 7951755

Intravenous gammaglobulin, 2: Pharmacology, clinical uses and mechanisms of action.

R I Schiff1.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7951755     DOI： 10.1111/j.1399-3038.1994.tb00230.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN： 0905-6157            Impact factor:   6.377


× No keyword cloud information.
  4 in total

1.  Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo.

Authors:  John H Vernachio; Arnold S Bayer; Brenda Ames; Dawn Bryant; Bradley D Prater; Peter J Syribeys; Elena L Gorovits; Joseph M Patti
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Multicenter crossover comparison of the safety and efficacy of Intraglobin-F with Gamimune-N, Sandoglobulin, and Gammagard in patients with primary immunodeficiency diseases.

Authors:  R I Schiff; L W Williams; R P Nelson; R H Buckley; W Burks; R A Good
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

3.  Efficacy and tolerability of an argentine intravenous immunoglobulin in pediatric patients with primary immunodeficiency diseases.

Authors:  S Krasovec; A Ornani; M Oleastro; S Rosenzweig; A Roy; L Perez; G Campos; N Marín; A Martinez; C Mahieu; M J Manfredi; A Sisti; M Zelazko
Journal:  J Clin Immunol       Date:  2007-01-19       Impact factor: 8.317

Review 4.  Efficacy of Intravenous Immunoglobulin in Neurological Diseases.

Authors:  Jan D Lünemann; Isaak Quast; Marinos C Dalakas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.